CD8+ T Cells Responding to the Middle East Respiratory Syndrome Coronavirus Nucleocapsid Protein Delivered by Vaccinia Virus MVA in Mice

CD8+ T Cells Responding to the Middle East Respiratory Syndrome Coronavirus Nucleocapsid Protein Delivered by Vaccinia Virus MVA in Mice

Middle East respiratory syndrome coronavirus (MERS-CoV), a novel infectious agent causing severe respiratory disease and death in humans, was first described in 2012. Antibodies directed against the MERS-CoV spike (S) protein are thought to play a major role in controlling MERS-CoV infection and in...

Full description

Bibliographic Details
Main Authors: Svenja Veit, Sylvia Jany, Robert Fux, Gerd Sutter, Asisa Volz
Format: Article
Language:English
Published: MDPI AG 2018-12-01
Series:Viruses
Subjects:
MERS-CoV
MERS-CoV nucleocapsid protein
murine CD8+ T cell epitope
MVA vaccine
Online Access:https://www.mdpi.com/1999-4915/10/12/718

Similar Items

Similar Items